These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 27738313)
1. SOX17 is a tumor suppressor in endometrial cancer. Zhang Y; Bao W; Wang K; Lu W; Wang H; Tong H; Wan X Oncotarget; 2016 Nov; 7(46):76036-76046. PubMed ID: 27738313 [TBL] [Abstract][Full Text] [Related]
2. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer. Li L; Yang WT; Zheng PS; Liu XF Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906 [TBL] [Abstract][Full Text] [Related]
3. ZBTB7A regulates LncRNA HOTAIR-mediated ELAVL1/SOX17 axis to inhibit malignancy and angiogenesis in endometrial carcinoma. Zhang XH; Wu SW; Feng YF; Xie YQ; Li M; Hu P; Cao Y J Cancer Res Clin Oncol; 2024 Jul; 150(7):345. PubMed ID: 38981872 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma. Li JY; Han C; Zheng LL; Guo MZ Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318 [TBL] [Abstract][Full Text] [Related]
5. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis. Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer. Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859 [TBL] [Abstract][Full Text] [Related]
7. SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression. Liao YM; Song Y; Li YK; Du JH; Zhou Y Cancer Gene Ther; 2020 Apr; 27(3-4):256-263. PubMed ID: 31543512 [TBL] [Abstract][Full Text] [Related]
8. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer. Jia Y; Yang Y; Zhan Q; Brock MV; Zheng X; Yu Y; Herman JG; Guo M J Mol Diagn; 2012 Nov; 14(6):577-85. PubMed ID: 22921431 [TBL] [Abstract][Full Text] [Related]
10. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma. Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954 [TBL] [Abstract][Full Text] [Related]
11. SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer. Yin D; Jia Y; Yu Y; Brock MV; Herman JG; Han C; Su X; Liu Y; Guo M Discov Med; 2012 Jul; 14(74):33-40. PubMed ID: 22846201 [TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signalling regulates Sox17 expression and is essential for organizer and endoderm formation in the mouse. Engert S; Burtscher I; Liao WP; Dulev S; Schotta G; Lickert H Development; 2013 Aug; 140(15):3128-38. PubMed ID: 23824574 [TBL] [Abstract][Full Text] [Related]
13. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931 [TBL] [Abstract][Full Text] [Related]
14. Sox17 and β-catenin co-occupy Wnt-responsive enhancers to govern the endoderm gene regulatory network. Mukherjee S; Chaturvedi P; Rankin SA; Fish MB; Wlizla M; Paraiso KD; MacDonald M; Chen X; Weirauch MT; Blitz IL; Cho KW; Zorn AM Elife; 2020 Sep; 9():. PubMed ID: 32894225 [TBL] [Abstract][Full Text] [Related]
16. Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation. Chen HL; Chew LJ; Packer RJ; Gallo V Cancer Lett; 2013 Jul; 335(2):361-71. PubMed ID: 23474492 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA steroid receptor activator promotes the progression of endometrial cancer via Wnt/ β-catenin signaling pathway. Park SA; Kim LK; Kim YT; Heo TH; Kim HJ Int J Biol Sci; 2020; 16(1):99-115. PubMed ID: 31892849 [No Abstract] [Full Text] [Related]
18. Prognostic and clinicopathological significance of TMEFF2, SMOC-2, and SOX17 expression in endometrial carcinoma. Alabiad MA; Harb OA; Hefzi N; Ahmed RZ; Osman G; Shalaby AM; Alnemr AA; Saraya YS Exp Mol Pathol; 2021 Oct; 122():104670. PubMed ID: 34339705 [TBL] [Abstract][Full Text] [Related]
19. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer. Xu R; Hu J; Zhang T; Jiang C; Wang HY Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037 [TBL] [Abstract][Full Text] [Related]
20. Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer. Onishi H; Yamasaki A; Kawamoto M; Imaizumi A; Katano M Cancer Lett; 2016 Feb; 371(2):143-50. PubMed ID: 26655998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]